264 related articles for article (PubMed ID: 24641873)
21. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
22. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
23. PIK3CA mutations matter for cancer in dogs.
Kim JH
Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
[TBL] [Abstract][Full Text] [Related]
24. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
25. Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.
London CA; Gardner H; Zhao S; Knapp DW; Utturkar SM; Duval DL; Chambers MR; Ostrander E; Trent JM; Kuffel G
Vet Comp Oncol; 2023 Dec; 21(4):565-577. PubMed ID: 37778398
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-like proteins in the DNA damage response: the next generation.
Da Costa IC; Schmidt CK
Essays Biochem; 2020 Oct; 64(5):737-752. PubMed ID: 32451552
[TBL] [Abstract][Full Text] [Related]
27. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
28. Dynamic In Vivo Profiling of DNA Damage and Repair after Radiotherapy Using Canine Patients as a Model.
Schulz N; Chaachouay H; Nytko KJ; Weyland MS; Roos M; Füchslin RM; Guscetti F; Scheidegger S; Rohrer Bley C
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587165
[TBL] [Abstract][Full Text] [Related]
29. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.
Thumser-Henner P; Nytko KJ; Rohrer Bley C
BMC Vet Res; 2020 Jan; 16(1):30. PubMed ID: 32005245
[TBL] [Abstract][Full Text] [Related]
30. Molecular carcinogenesis of canine mammary tumors: news from an old disease.
Klopfleisch R; von Euler H; Sarli G; Pinho SS; Gärtner F; Gruber AD
Vet Pathol; 2011 Jan; 48(1):98-116. PubMed ID: 21149845
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of DNA ploidy in canine mammary tumors.
Rutteman GR; Cornelisse CJ; Dijkshoorn NJ; Poortman J; Misdorp W
Cancer Res; 1988 Jun; 48(12):3411-7. PubMed ID: 3370639
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel genes involved in DNA damage response by screening a genome-wide Schizosaccharomyces pombe deletion library.
Pan X; Lei B; Zhou N; Feng B; Yao W; Zhao X; Yu Y; Lu H
BMC Genomics; 2012 Nov; 13():662. PubMed ID: 23173672
[TBL] [Abstract][Full Text] [Related]
33. The Role of Bcl-xL Protein Research in Veterinary Oncology.
Pawlak A; Henklewska M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260403
[TBL] [Abstract][Full Text] [Related]
34. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.
MacEwen EG
Cancer Metastasis Rev; 1990 Sep; 9(2):125-36. PubMed ID: 2253312
[TBL] [Abstract][Full Text] [Related]
36. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
37. Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy.
Li L; Kumar AK; Hu Z; Guo Z
Curr Med Chem; 2021; 28(5):963-985. PubMed ID: 32091326
[TBL] [Abstract][Full Text] [Related]
38. An insight into the mechanism of DNA damage response in plants- role of SUPPRESSOR OF GAMMA RESPONSE 1: An overview.
Mahapatra K; Roy S
Mutat Res; 2020; 819-820():111689. PubMed ID: 32004947
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
Patil SS; Gentschev I; Nolte I; Ogilvie G; Szalay AA
J Transl Med; 2012 Jan; 10():3. PubMed ID: 22216938
[TBL] [Abstract][Full Text] [Related]
40. Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency.
Kerzendorfer C; O'Driscoll M
DNA Repair (Amst); 2009 Sep; 8(9):1139-52. PubMed ID: 19473885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
